Cargando…
Heteroaromatic ester inhibitors of hepatitis A virus 3C proteinase: Evaluation of mode of action
The related 3C and 3C-like proteinase (3C(pro) and 3CL(pro)) of picornaviruses and coronaviruses, respectively, are good drug targets. As part of an effort to generate broad-spectrum inhibitors of these enzymes, we screened a library of inhibitors based on a halopyridinyl ester from a previous study...
Autores principales: | Huitema, Carly, Zhang, Jianmin, Yin, Jiang, James, Michael N.G., Vederas, John C., Eltis, Lindsay D. |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Elsevier Ltd.
2008
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7125897/ https://www.ncbi.nlm.nih.gov/pubmed/18407505 http://dx.doi.org/10.1016/j.bmc.2008.03.059 |
Ejemplares similares
-
Aryl methylene ketones and fluorinated methylene ketones as reversible inhibitors for severe acute respiratory syndrome (SARS) 3C-like proteinase
por: Zhang, Jianmin, et al.
Publicado: (2008) -
An Episulfide Cation (Thiiranium Ring) Trapped in the Active Site of HAV 3C Proteinase Inactivated by Peptide-based Ketone Inhibitors
por: Yin, Jiang, et al.
Publicado: (2006) -
High-Throughput Screening Identifies Inhibitors of the SARS Coronavirus Main Proteinase
por: Blanchard, Jan E., et al.
Publicado: (2004) -
A Mechanistic View of Enzyme Inhibition and Peptide Hydrolysis in the Active Site of the SARS-CoV 3C-like Peptidase
por: Yin, Jiang, et al.
Publicado: (2007) -
Synthesis and testing of azaglutamine derivatives as inhibitors of Hepatitis A Virus (HAV) 3C proteinase
por: Huang, Yanting, et al.
Publicado: (1999)